Pacira BioSciences Inc. will join the S&P SmallCap 600 index, replacing digital imaging company Shutterfly Inc., effective before trading opens Sept. 30.
Parsippany, N.J.-based Pacira BioSciences develops non-opioid pain management therapies in the U.S. The company will join the S&P SmallCap 600 Global Industry Classification Standard Pharmaceuticals Sub-Industry index.
Shutterfly is being acquired by private equity firm Apollo Global Management Inc. in a deal valued at $2.7 billion.
S&P Dow Jones Indices and S&P Global Market Intelligence are owned by S&P Global Inc.
